683 Capital Management’s Amicus Therapeutics FOLD Stock Holding History

683 Capital Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-775,000	Closed	-$11.2M	–	184
2026 Q1	$11.2M	Sell	775,000 -25,000	-3%	-$358K	0.58%	38
2025 Q4	$11.4M	Sell	800,000 -35,000	-4%	-$344K	0.5%	43
2025 Q3	$6.58M	Sell	835,000 -125,000	-13%	-$890K	0.34%	60
2025 Q2	$5.5M	Buy	960,000 +685,000	+249%	+$4.42M	0.36%	71
2025 Q1	$2.24M	Buy	+275,000	New	+$2.54M	0.15%	106

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

683 Capital Management's FOLD Position: Q2 2026 in Review

683 Capital Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 775,000 shares — an estimated $11.2M sold.

683 Capital Management first reported a position in FOLD in Q1 2025 and held it in 5 quarters. The position peaked at $11.4M in Q4 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

683 Capital Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
683 Capital Management sold 775,000 Amicus Therapeutics shares in Q2 2026, an estimated $11.2M.
683 Capital Management first reported a position in Amicus Therapeutics in Q1 2025 and held it in 5 quarters.
683 Capital Management's Amicus Therapeutics position peaked at $11.4M in Q4 2025.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on 683 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.